A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor
Clinical trial NCT05148533 · TERMINATED
Trial details
- NCT number
- NCT05148533
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2023-02-03
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.